Human medicines European public assessment report (EPAR): Temozolomide Teva, temozolomide, Date of authorisation: 28/01/2010, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Temozolomide Teva, temozolomide, Date of authorisation: 28/01/2010, Revision: 22, Status: Authorised

Records of data processing activity for study of the “Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV- during the Omicron period”

Records of data processing activity for study of the “Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV- during the Omicron period”

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness